Department of Critical Care Medicine, The Central Hospital of Dazhou, Dazhou 635000, Sichuan, China.
Ophthalmology, The Central Hospital of Dazhou, Dazhou 635000, Sichuan, China.
Can Respir J. 2022 Mar 31;2022:4579030. doi: 10.1155/2022/4579030. eCollection 2022.
The effects of prone positioning (PP) on patients with acute respiratory distress syndrome (ARDS) caused by pulmonary contusion (PC) are unclear. We sought to determine the efficacy of PP among patients whose ARDS was caused by PC.
A retrospective observational study was performed at an intensive care unit (ICU) from January 2017 to June 2021. ARDS patients with PaO/FiO (P/F) < 150 mmHg were enrolled. During the study period, we enrolled 121 patients in the PP group and 117 in the control group. The changes in vital signs, laboratory tests, and compliance of the respiratory system (Crs) were recorded for 3 consecutive days. The mechanical ventilation time, duration of ICU stay, complications, extubation rate, 28-day ventilator-free days, and mortality were also recorded.
In the PP group, the P/F and Crs increased over time. Compared to the control group, the P/F and Crs improved in the PP group over 3 consecutive days ( < 0.05). Furthermore, the PP group also had shorter total mechanical ventilation time (5.1 ± 1.4 vs. 9.3 ± 3.1 days, < 0.05) and invasive ventilation time (4.9 ± 1.2 vs. 8.7 ± 2.7 days, < 0.05), shorter ICU stay (7.4 ± 1.8 vs. 11.5 ± 3.6days, < 0.05), higher extubation rate (95.6% vs. 84.4%, < 0.05), less atelectasis (15 vs. 74, < 0.05) and pneumothorax (17 vs. 24, > 0.05), more 28-day ventilator-free days (21.6 ± 5.2 vs. 16.2 ± 7.2 days, < 0.05), and lower mortality (4.4% vs. 13.3%, < 0.05).
Among PC cases with moderate to severe ARDS, PP can correct hypoxemia more quickly, improve Crs, reduce atelectasis, increase the extubation rate, shorten mechanical ventilation time and length of ICU stay, and reduce mortality.
俯卧位(PP)对创伤性肺挫伤(PC)导致的急性呼吸窘迫综合征(ARDS)患者的影响尚不清楚。我们旨在确定 ARDS 由 PC 引起的患者中 PP 的疗效。
这是一项于 2017 年 1 月至 2021 年 6 月在重症监护病房(ICU)进行的回顾性观察性研究。纳入 PaO/FiO(P/F)<150mmHg 的 ARDS 患者。在研究期间,PP 组纳入 121 例患者,对照组纳入 117 例患者。连续 3 天记录生命体征、实验室检查和呼吸系统顺应性(Crs)的变化。还记录了机械通气时间、ICU 住院时间、并发症、拔管率、28 天无呼吸机天数和死亡率。
在 PP 组中,P/F 和 Crs 随时间增加。与对照组相比,PP 组在连续 3 天内 P/F 和 Crs 改善(<0.05)。此外,PP 组的总机械通气时间(5.1±1.4 与 9.3±3.1 天,<0.05)和有创通气时间(4.9±1.2 与 8.7±2.7 天,<0.05)更短,ICU 住院时间(7.4±1.8 与 11.5±3.6 天,<0.05)更短,拔管率(95.6% 与 84.4%,<0.05)更高,肺不张(15 例与 74 例,<0.05)和气胸(17 例与 24 例,>0.05)更少,28 天无呼吸机天数(21.6±5.2 与 16.2±7.2 天,<0.05)更多,死亡率(4.4% 与 13.3%,<0.05)更低。
在中度至重度 ARDS 的 PC 病例中,PP 可以更快地纠正低氧血症,改善 Crs,减少肺不张,提高拔管率,缩短机械通气时间和 ICU 住院时间,降低死亡率。